Dr. Biron joined the Faculty of Pharmacy at Université Laval in 2008 after obtaining a PhD in chemistry from Université Laval and a postdoctoral fellowship in pharmaceutical chemistry at the Technical University of Munich. Researcher at the CHU de Québec-Université Laval Research Center and member of the Institute of Nutrition and Functional Foods, Dr. Biron is interested in the discovery and development of new antimicrobial agents based on peptides and natural products. Its research program revolves around three axes: 1) the development of synthetic approaches to produce antimicrobial peptides and biosourced molecules; 2) the use of peptidomimetism for the optimization of the pharmacological properties of antimicrobial peptides; 3) the design and study of conjugate and hybrid antimicrobial peptides. The work of his team has recently led to the development of synthetic routes for several bacteriocins and their analogs with improved pharmacological properties and stabilities. Among other achievements, his laboratory has developed, in collaboration with the team of Dr. Ismail Fliss, a pediocin PA-1 analog with improved properties which is now approved by Health Canada as an antimicrobial technological agent for food applications and is commercially produced.